Moexipril and left ventricular hypertrophy

about

Moexipril and left ventricular hypertrophy

Item

http://www.wikidata.org/entity/Q36013111

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Moexipril and left ventricular hypertrophy

@ast

Moexipril and left ventricular hypertrophy

@en

type

Item

label

Moexipril and left ventricular hypertrophy

@ast

Moexipril and left ventricular hypertrophy

@en

prefLabel

Moexipril and left ventricular hypertrophy

@ast

Moexipril and left ventricular hypertrophy

@en

P1476

Moexipril and left ventricular hypertrophy

@en

P2093

George S Chrysant

http://www.w3.org/2001/XMLSchema#string

P K Nguyen

http://www.w3.org/2001/XMLSchema#string

P2860

Synthesis of novel angiotensin converting enzyme inhibitor quinapril and related compounds. A divergence of structure-activity relationships for non-sulfhydryl and sulfhydryl types.

Long-term safety and efficacy of moexipril alone and in combination with hydrochlorothiazide in elderly patients with hypertension.

The renin-angiotensin system and vascular hypertrophy.

Vascular remodeling: the role of angiotensin-converting enzyme inhibitors.

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update.

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Effects of moexiprilat on oestrogen-stimulated cardiac fibroblast growth

Benazepril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and congestive heart failure.

P304

23-30

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17583172

http://www.w3.org/2001/XMLSchema#string

P921

mechanism of action

P932

1994034

http://www.w3.org/2001/XMLSchema#string